Insufficient scRNA-seq data for expression of MAP3K15 at single-cell level.
Insufficient scRNA-seq data for expression of MAP3K15 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 3875.53 | 258 / 258 | 41% | 5.93 | 94 / 230 |
kidney | 100% | 229.76 | 89 / 89 | 23% | 0.72 | 209 / 901 |
pancreas | 99% | 58.08 | 326 / 328 | 17% | 0.99 | 30 / 178 |
ovary | 98% | 103.87 | 177 / 180 | 10% | 0.20 | 41 / 430 |
spleen | 100% | 490.94 | 241 / 241 | 0% | 0 | 0 / 0 |
lung | 74% | 37.79 | 426 / 578 | 6% | 0.15 | 69 / 1155 |
peripheral blood | 78% | 28.78 | 727 / 929 | 0% | 0 | 0 / 0 |
uterus | 69% | 19.23 | 117 / 170 | 5% | 0.09 | 23 / 459 |
brain | 67% | 21.17 | 1777 / 2642 | 5% | 0.13 | 37 / 705 |
stomach | 50% | 8.86 | 179 / 359 | 3% | 0.04 | 8 / 286 |
breast | 43% | 6.47 | 199 / 459 | 1% | 0.03 | 6 / 1118 |
thymus | 41% | 5.51 | 269 / 653 | 0% | 0.01 | 2 / 605 |
intestine | 36% | 4.46 | 352 / 966 | 2% | 0.05 | 12 / 527 |
prostate | 31% | 3.71 | 77 / 245 | 0% | 0 | 0 / 502 |
blood vessel | 31% | 4.33 | 415 / 1335 | 0% | 0 | 0 / 0 |
heart | 27% | 3.23 | 235 / 861 | 0% | 0 | 0 / 0 |
adipose | 22% | 2.84 | 269 / 1204 | 0% | 0 | 0 / 0 |
esophagus | 17% | 1.86 | 240 / 1445 | 5% | 0.13 | 9 / 183 |
skin | 16% | 1.92 | 298 / 1809 | 4% | 0.12 | 21 / 472 |
bladder | 14% | 1.52 | 3 / 21 | 1% | 0.02 | 7 / 504 |
muscle | 15% | 1.83 | 122 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 13% | 0.33 | 6 / 45 |
liver | 5% | 0.45 | 12 / 226 | 6% | 0.11 | 23 / 406 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0033554 | Biological process | cellular response to stress |
GO_0000165 | Biological process | MAPK cascade |
GO_0004709 | Molecular function | MAP kinase kinase kinase activity |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0005524 | Molecular function | ATP binding |
Gene name | MAP3K15 |
Protein name | Mitogen-activated protein kinase kinase kinase 15 Mitogen-activated protein kinase kinase kinase 15 (EC 2.7.11.25) (Apoptosis signal-regulating kinase 3) (MAPK/ERK kinase kinase 15) (MEK kinase 15) (MEKK 15) |
Synonyms | ASK3 |
Description | FUNCTION: Serine/threonine kinase which acts as a component of the MAP kinase signal transduction pathway . Once activated, acts as an upstream activator of the p38 MAPK signal transduction cascade through the phosphorylation and activation of several MAP kinase kinases . May function in a signal transduction pathway that is activated by various cell stresses and leads to apoptosis . Involved in phosphorylation of WNK4 in response to osmotic stress or hypotonic low-chloride stimulation via the p38 MAPK signal transduction cascade . . |
Accessions | ENST00000338883.9 [Q6ZN16-1] ENST00000359173.7 A0A140T8W5 Q6ZN16 |